A comprehensive view of vaccination / immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Biopharma firm CureVac NV and the University of Texas MD Anderson Cancer Center partner to develop novel mRNA-based cancer vaccines; the collaboration will focus on creating vaccines for hematological and solid tumor indications
Published: April 18, 2024 by Marketline - Deals
AstraZeneca to present new data on its vaccine & immune therapies portfolio at the 34th European Congress of Clinical Microbiology & Infectious Diseases; the company will showcase 19 abstracts
Published: April 18, 2024 by PharmaBiz (India)
Novavax's updated non-mRNA COVID-19 vaccine, Nuvaxovid XBB.1.5, now available in UK for 2024 vaccination season following receipt of wholesale license and green book update
Published: April 18, 2024 by Novavax Inc.
INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "RNA CONSTRUCTS AND USES THEREOF"
Published: April 17, 2024 by U.S. Fed News
Moderna to report first quarter 2024 financial results on Thursday, May 2, 2024
Published: April 17, 2024 by Moderna Inc.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count